JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Friedhelm Beyersdorf
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beyersdorf, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beyersdorf, F.

J Thorac Cardiovasc Surg 1997;113:426
© 1997 Mosby, Inc.


LETTERS TO THE EDITOR

Controlled limb reperfusion in patients with severe limb ischemia

Friedhelm Beyersdorf, MD

Department of Cardiovascular Surgery
Albert-Ludwigs-Universität Freiburg
79106 Freiburg, Germany

Reply to the Editor:

My colleagues and I thank Drs. Sakakibara and Mitsui for their interest in our work and for raising the important question of the effluent return to the systemic circulation.

Undoubtedly, the venous effluent of limbs reperfused after several hours of complete ischemia contains greater amounts of myoglobin, free hemoglobin, creatine kinase, and potassium than do control limbs. After complete ischemia, this has been shown in experimentalGo 1 and clinicalGo 2 studies. To a lesser degree, this increase was also measurable after revascularization for incomplete ischemia.Go 3

These components in the venous effluent are a consequence of the severe local damage of skeletal muscle (rhabdomyolysis, edema) and are the cause for systemic complications (hyperkalemia, myoglobinemia, acute renal failure, acidosis, multiorgan failure, and death) following revascularization after prolonged periods of limb ischemia.

Our limb reperfusion strategy has been developed to decrease the skeletal muscle reperfusion injury after revascularizations for prolonged ischemia. Less local damage will result in reduced concentrations of potassium, creatine kinase, and hydrogen ions in the venous effluent, which could be demonstrated in an experimental study.Go 1 Nevertheless, the venous effluent, even after controlled limb reperfusion, still contains significant amounts of end products of the rhabdomyolysis, which can only be prevented from entering the systemic circulation by discarding the venous effluent. Simply discarding the venous effluent is not possible because of the large amount of blood that would be lost. The same is true for any filtering process. The only possibility is to separately cannulate the femoral arteries and veins and use an extracorporeal circulation including oxygenator and roller pumps. This approach was recently described by Vogt and coworkersGo 2 from the Zürich group in a patient with complete ischemia for 24 hours.

The concentrations of myoglobin, potassium, and creatine kinase in the venous effluent are related to the severity of ischemia (complete/incomplete) (1/3) and the duration of ischemia (2/4). The more severe the ischemic insult, the more pronounced is the reperfusion damage, resulting in higher concentrations in the venous effluent. In our three-center study,Go 4 we were able to reduce the concentrations of myoglobin, potassium, and creatine kinase to a level that did not produce systemic hyperkalemia or renal failure. However, Vogt and coworkersGo 2 have used a complete extracorporeal circuit (including an oxygenator) for a patient with complete ischemia for 24 hours and achieved excellent results with this approach. In patients with complete ischemia exceeding 24 to 36 hours, it might very well be necessary to discard the venous effluent and use an extracorporeal circuit to prevent severe systemic side effects. In our study with a mean ischemic time of 26 hours (range 6 to 39 hours), we did see systemic increases in potassium, creatine kinase, creatinine, and blood urea nitrogen; however, this did not produce remote organ failure. Even though we did not measure myoglobin concentrations in our patients, the fact that none had severe renal failure shows that there was no major renal tubular dysfunction.

Ideally, future refinements in the technique of controlled limb reperfusion will elucidate criteria, identify which patients will need controlled limb reperfusion without complete extracorporeal circulation, and define those patients who need controlled reperfusion with venous effluent discardment.

12/8/77666

References

  1. Mitrev Z, Beyersdorf F, Hallmann R, Poloczek Y, Ihnken K, Herold H, et al. Reperfusion injury in skeletal muscle: controlled limb reperfusion reduces local and systemic complications after prolonged ischemia. Cardiovasc Surg 1994;2:737-48.
  2. Vogt PR, von Segesser LK, Pagotto E, Lijovic T, Turina MI. Simplified controlled limb reperfusion and simultaneous revascularization for acute aortic occlusion. J Vasc Surg 1996;23:730-3.
  3. Ihnken K, Beyersdorf F, Mitrev Z, Unkelbach U, Poloczek Y, Hallmann R, et al. Controlled reperfusion reduces reperfusion injury in skeletal muscle after incomplete limb ischemia. Vasc Surg 1994;28:241-60.
  4. Beyersdorf F, Mitrev Z, Ihnken K, Schmiedt W, Sarai K, Eckel L, et al. Controlled limb reperfusion in patients having cardiac operations. J Thorac Cardiovasc Surg 1996;111:873-81.




This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Friedhelm Beyersdorf
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beyersdorf, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beyersdorf, F.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS